Detalles de la búsqueda
1.
Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.
Eur J Haematol
; 111(6): 863-871, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37670560
2.
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia.
Cancer
; 128(7): 1411-1417, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34931301
3.
Survival of patients with newly diagnosed high-grade myeloid neoplasms who do not meet standard trial eligibility.
Haematologica
; 106(8): 2114-2120, 2021 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646891
4.
Financial Implications of Early Hospital Discharge After AML-Like Induction Chemotherapy: A 4-Year Retrospective Analysis.
J Natl Compr Canc Netw
; : 1-10, 2021 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34161925
5.
Impact of clinical, cytogenetic, and molecular profiles on long-term survival after transplantation in patients with chronic myelomonocytic leukemia.
Haematologica
; 105(3): 652-660, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31289199
6.
Outpatient induction and consolidation care strategies in acute myeloid leukemia.
Curr Opin Hematol
; 26(2): 65-70, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30585894
7.
Intensive chemotherapy for acute myeloid leukemia relapse after allogeneic hematopoietic cell transplantation.
Am J Hematol
; 97(6): E220-E223, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35303371
8.
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia.
Invest New Drugs
; 33(2): 371-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25483416
9.
Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.
Haematologica
; 104(4): e143-e146, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30409798
10.
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial.
JAMA Oncol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722664
11.
Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms.
Transplant Cell Ther
; 2024 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38710302
12.
Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents.
Leuk Lymphoma
; 64(5): 990-996, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36891630
13.
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms.
Leukemia
; 37(2): 298-307, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36509892
14.
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.
Blood Adv
; 7(17): 4950-4961, 2023 09 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37339483
15.
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia.
Leuk Lymphoma
; 64(5): 927-937, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36938892
16.
Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia.
Blood
; 126(26): 2790-7, 2015 Dec 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-26504183
17.
Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy.
Leuk Lymphoma
; 63(1): 142-151, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34608844
18.
Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms.
Cancers (Basel)
; 14(12)2022 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740603
19.
Practice patterns and outcomes for adults with acute myeloid leukemia receiving care in community vs academic settings.
Hematology Am Soc Hematol Educ Program
; 2020(1): 129-134, 2020 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33275691
20.
Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm.
J Clin Oncol
; 38(35): 4163-4174, 2020 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33030979